Download presentation
Presentation is loading. Please wait.
1
Yes No Yes Yes No No Yes No Yes No
Hypereosinophilia with end-organ damage Yes Treat with corticosteroids Is emergency treatment required? (i.e. life-threatening organ involvement) No Treat as per idiopathic HES* Yes Yes Is it LV-HES? Is the eosinophilia reactive? No No Treat underlying cause Is there a primary (clonal) eosinophilia? Yes No Is there a confirmed molecular target? Treat as per idiopathic HES* Yes No Treat with TKI or JAK2 inhibitor therapy Treat as appropriate for a myeloid neoplasm *Treatments include corticosteroids, trial of TKI therapy, interferon, ciclosporin, azathioprine, hydroxycarbamide. See text for details. HES, hypereosinophilic syndrome: LV-HES, lymphocyte variant hypereosinophilic syndrome; TKI, tyrosine kinase inhibitor
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.